Cargando…
The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
BACKGROUND: At present, the primary treatment of esophageal cancer is surgery-based comprehensive treatment, including adjuvant therapy such as chemotherapy and/or radiotherapy. However, the role of adjuvant therapy for esophageal squamous cell carcinoma (ESCC) with pathologically node-negative (pN0...
Autores principales: | Deng, Xuyang, He, Wenwu, Jiang, Yingchun, Deng, Sijie, Mao, Tianqin, Leng, Xuefeng, Luo, Qiyu, Zheng, Kai, Han, Yongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267332/ https://www.ncbi.nlm.nih.gov/pubmed/34277798 http://dx.doi.org/10.21037/atm-21-2539 |
Ejemplares similares
-
Moderately differentiated esophageal squamous cell carcinoma has a poor prognosis after neoadjuvant chemoradiotherapy
por: He, Wenwu, et al.
Publicado: (2021) -
MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
por: Luo, Qiyu, et al.
Publicado: (2021) -
Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020) -
Impact of adjuvant chemotherapy for radically resected esophageal squamous cell carcinoma: a propensity score matching analysis
por: Chen, Shao-bin, et al.
Publicado: (2023) -
Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History
por: He, Wenwu, et al.
Publicado: (2020)